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Ions near the high-end border of a mass defect distribution plot for native peptide fragment
ions have potential as signature markers that are based on mass-to-charge ratio determination.
The specificity of these marker ions, including phosphoryl ions, can be improved by removing
interfering isobaric ions from the border region on the distribution plot. These interfering ions
are rich in Asp and Glu content. The masses of amino acid residues and peptides are rescaled
from the IUPAC scale (12C 12 u as the mass reference) to the averagine scale (averagine mass
111 u* as the mass reference with zero mass defect; u*: the mass unit on the averagine scale),
using a scaling factor of 0.999493894. It is theoretically predicted that esterification of Asp and Glu
side-chain carboxylates with n-butanol can achieve a sufficient retreat of the high-end border on a
mass defect distribution plot based on the use of mass spectrometers with better-than-medium
resolution. Theoretical calculations and laboratory experiments are performed to examine effects of
various esterifications on the averagine-scale mass defect distribution of peptide fragment ions and
on the specificity of two positive phosphoryl ions: the phosphotyrosine immonium ion and a
cyclophosphoramidate ion. (J Am Soc Mass Spectrom 2009, 20, 2124–2134) © 2009 American
Society for Mass SpectrometryMass defects of peptides are limited to a definedrange, and mass spectral peaks are discretelypopulated within each mass-to-charge unit.
This is because the 20 common amino acids, compo-
nents of peptides, have limited elemental compositions
(C, H, N, O, and S). Separating regions existing between
adjacent peak-groups are not occupied by any native
peptide (and/or fragment) ions; they are termed forbid-
den zones [1–3]. By definition, the mass defect of an
atom is the difference between the sum of constituent
nucleons and the measured mass of the atom. In mass
spectrometry, the mass defect is often referred to as the
difference between the exact mass and the nominal
mass (rounded exact mass) of an ion. On the Interna-
tional Union of Pure and Applied Chemistry (IUPAC)
scale, the mass defect of carbon-12 is set to be zero. The
overall mass defect of a peptidyl ion is mainly deter-
mined by the mass defect of the hydrogen atom. Mass
defects of nitrogen and oxygen atoms, with similar
abundance in naturally occurring proteins, are similar
but opposite in sign; therefore, the net effect of these
two elements on the overall peptide mass defect is
small. The low abundance sulfur plays a minor role in
affecting the overall mass defect of a peptide ion, but a
significant role in small fragment ions.
A majority of studies on the forbidden zone phenom-
enon [1–3] have been focused on the analysis of peptide
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mass spectrometers and sometimes time-of-flight mass
spectrometers [4–6]. Using the National Center for
Biotechnology Information protein database, the mass
distribution of singly charged tryptic peptides has been
analyzed [4]. The average fractional mass (m) of intact
peptides increases with the monoisotopic mass (m),
according to the following equation [4]. Similar equa-
tions have also been presented previously [1, 3, 7].
m 4.7831 104m 0.0279
In addition, the upper and lower boundaries of the
peptide fractional mass distribution are calculated;
within these boundaries are found roughly 99% of the
peptide ions. The width between the boundaries
[W(m)] has been defined by the following equation [4]:
W(m) 1.9107 104m 0.0741
Together, these two equations define the most prob-
able fractional mass values that peptides can populate
for a particular monoisotopic mass [4].
Masses of peptide fragment ions can be analyzed with
a scaling analysis method, in which ion masses are
rescaled using averagine [8] as the mass reference and
the mass defect of averagine is defined to be zero [9].
Averagine-scaling analysis is an application of the hy-
pothetical averagine amino acid residue, originally pro-
posed in 1995 [8]. As an important advantage, rescaled
mass defects of peptide fragment ions have little depen-
dence on the ion mass, which allows application of
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unoccupied spectral regions [9].
There are two general chemical approaches to shift
mass defects of peptide fragment ions away from the
borders of a mass defect distribution plot [9] for native
peptide fragment ions. A mass defect distribution plot
is referred to as a plot of ion counts versus ion mass
defects [9]. One approach is to increase mass defects of
certain classes of ions. These modifying groups carry
large mass defect atoms, including bromine and chlo-
rine [10–12]; more recent studies employ iodine-based
ones [9]. Similarly, performic acid oxidation also shifts
Cys-, Met-, and Trp-containing ions to the high-end
border of a mass defect distribution plot; the oxidation
converts Cys to CysO3, Met to MetO2, and Trp to TrpO2,
and increases the mass defects of modified ions by
introducing oxygen atoms [13]. The other approach is to
decrease mass defect of selected groups of ions. These
ions commonly have a large content of oxygen atoms,
e.g., y-type fragment ions that have multiple carboxy-
lates on side chains (Asp and Glu residues) and at the
C-terminus. Decreasing the Asp/Glu content of pep-
tides by using Glu-C as an endoprotease results in a
concomitant decrease in the mass defect, and thus
decreases the population of peptide ions with large
mass defects [14]. In theory, these carboxylate groups
can be esterified with aliphatic alcohols, and thus mass
defects of corresponding ions decrease due to introduc-
tion of multiple hydrogen atoms. Esterification is a
common sample preparation procedure prior to mass
spectrometric analysis of phosphopeptides, which pro-
duces phosphoryl ions upon gas-phase dissociation.
The specificity of these phosphoryl ions during mass
analysis is expected to increase if carboxylate-rich frag-
ment ions are pushed away with decreased mass de-
fects due to the esterification.
Ions in forbidden zone or unoccupied spectral space
are highly specific. They have been used to introduce
internal calibrants for mass spectrometry [15], to improve
proteome profiling [5, 7, 9–12], to analyze peptide-
oligonucleotide cross-links [16], and to determine pro-
tein post-translational modifications [17–22]. Due to the
relatively large mass defects of oxygen and phosphorus
atoms, phosphoryl fragment ions intersect with the
unoccupied spectral space and are separated from most
of isobaric native peptide fragment ions. The mass
separation is detectable with mass spectrometers of
better-than-medium mass resolution [18–22]. For exam-
ple, the phosphotyrosine (pY) immonium ion has been
used as a specific marker ion for precursor-scan tandem
mass spectrometry [19, 20]. Recent advances in mass
spectrometry instrumentation have lifted some techni-
cal limitations, including the low duty cycle of this
method for complex phosphoproteome analysis and a
revived use of the method is predictable [23]. Stable-
oxygen isotope labeling of pre-existing phosphates on
phosphoproteins employs pY immonium ions with differ-
ential oxygen stable isotopes for sequence-independent
quantitation of protein tyrosine phosphorylation, result-ing in minimal interference [21]. Aspired by the charac-
teristics of the pY immonium ion, phosphoserine peptides
have been modified in solution to produce a positively
charged cyclophosphoramidate (CyPAA) ion after gas-
phase reactions of modified peptides [22]. However,
both the pY immonium ion and the CyPAA ion overlap
with a small fraction of isobaric fragment ions [19–22],
thus limiting their use as marker ions for phosphate-
specific mass spectrometry. The isobaric ion interfer-
ence becomes increasingly significant when the resolu-
tion and accuracy of mass spectrometers decrease. This
work analyzes effects of esterification of peptidyl car-
boxylates on the mass defect distribution of peptide frag-
ment ions and on the improvement of the specificity of
phosphoryl fragment ions.
Experimental
Materials
Peptide labeled as YGK (sequence: YGGFLK) was pur-
chased from AnaSpec (San Jose, CA, USA). Chicken
ovalbumin, chicken lysozyme, bovine -lactalbumin,
bovine -lactoglobulin, bovine carbonic anhydrase, bo-
vine milk -casein, bovine milk -casein, bovine serum
albumin, and bovine trypsinogen were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Reagents were
purchased at better than reagent grade. Formic acid
(FA) was purchased from Fluka (Milwaukee, WI, USA).
Anhydrous methanol, anhydrous ethanol, anhydrous
propanol, anhydrous butanol, 3-iodobenzyl alcohol
(IBol), chlorotrimethylsilane (ClTMS), iodoacetamide
phosphatases inhibitor no. 1, phosphatases inhibitor no.
2, protease inhibitor cocktail, sodium orthovanadate,
hydrogen peroxide 35 wt.%, isopropanol, ethylenedia-
minetetraacetic acid (EDTA), phenylmethanesulpho-
nylfluoride (PMSF), and phosphate buffer saline (PBS)
10  pH 7.4 were purchased from Sigma-Aldrich (St.
Louis, MO, USA). Acetonitrile (ACN), acetic acid, dith-
ioerythritol (DTE), hexafluoroisopropanol (HFIP), and
2-mercaptoethanol (2-ME) were purchased from Fisher
(Pittsburgh, PA, USA). Trypsin (Roche Applied Sci-
ences, Indianapolis, IN, USA) was the sequence grade.
Deionized water was purified by a Direct-Q water
purifying system (Millipore, Billerica, M, USA). Drying
of samples was performed either on SpeedVac (Savant,
Farmingdale, NY, USA) or on a lyophilyzer (Labconco,
Kansas City, MO, USA). High-performance liquid chro-
matography (HPLC) was performed on a 10 ADvp
system (Shimadzu, Columbia, MD, USA) with Solvent
A of FA:ACN:H2O [2:10:988 (vol/vol/vol)] and Solvent
B of FA: H2O: ACN [2:10:988 (vol/vol/vol)]. Column
temperature was set at 60 °C. Separations of peptides
were carried out using a reversed-phase column (Hy-
persil GOLD, 1.9 m, 1.0  100 mmmm; Thermo
Scientific, Waltham, MA, USA). Mass spectrometry was
performed on a quadrupole time-of-flight tandem mass
spectrometer QSTAR Elite (Applied Biosystems, Foster
City, CA, USA).
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Peptide Fragment Ions
All peptide fragment ions were generated by an in-house
program written in the scripting language ActivePerl.
Isotope mass values of 1H (1.007825), 12C (12.000000), 14N
(14.003074), 16O (15.994914), and 32S (31.972070) were
used to calculate monoisotopic residual masses of all of
the amino acids. The monoisotopic residual mass of
cysteine was based on the S-carbamidomethyl residue.
All possible combinations of amino acid residual
masses were used to generate possible an, bn, and yn
fragment ions (n  1–8). Fragment ions containing two
amino acids were obtained by addition of monoisotopic
residual masses of two amino acids and subtracting
26.98,709 for all a2 fragment ions, adding 1.007825 for all
b2 ions and adding 19.018375 for all y2 fragment ions. In
addition, the possibility of all fragment ions containing
one 13C or two 13C was calculated by adding 1.003355
for one 13C and 2.00,671 for two 13C, respectively.
A script in ActivePerl was developed that employs a
loop that thoroughly enumerates all possible amino
acid additions to or subtractions from the initial for-
mula. Fragment ions studied contained up to eight
amino acid residues. The primary database generated
from this script contained the following fields: ion type,
sequence, and nominal mass of fragment ions. A second
script was developed to search for fragment ions from
this primary database; the ions were within a selected
range of nominal masses of interest.
Separate databases were generated for native pep-
tide fragment ions and those with methyl, ethyl, propyl,
and butyl esterification of peptidyl carboxylates. Frag-
ment ion mass distribution plots were generated using
Origin 8 (OriginLab, Northampton, MA, USA). Mass
defects of theoretical fragment ions from native and
modified peptides were converted to averagine-scale
mass defects. The conversion of IUPAC exact mass
(EMIUPAC), nominal mass (NMIUPAC, the round value of
EMIUPAC), and mass defect (MDIUPAC) of peptide ions to
those on the averagine scale was performed using
equations described in a previous paper [9], which
followed earlier equations used for studying ion mass
defect [24, 25]. Ion frequency for a defined range of the
averagine-scale mass defect (bin size  0.0075 u*) was
plotted against the averagine-scale mass defect of frag-
ment ions.
EMAvg (EMIUPAC) 0.999493894
NMAvgRound(EMAvg)
MDAvgNMIUPACEMAvg
Preparation of the Mixture of Nine-Protein Digest
A protein solution containing chicken ovalbumin, chicken
lysozyme, bovine -lactalbumin, bovine -lactoglobulin, bo-
vine carbonic anhydrase, bovine milk -casein, bovine
milk -casein, bovine serum albumin, and bovine
trypsinogen (22.2 g each) were lyophilized overnightand dissolved in 20 L buffer containing 8 M urea and
50 mM ammonium bicarbonate (NH4HCO3). This solu-
tion was treated with 2 L of 110 mM DTE in 50 mM
NH4HCO3 at 37 °C for 3 h, followed by addition of 2 L
of 600 mM iodoacetamide in 50 mM NH4HCO3. The
resulting solution was incubated in dark at room-
temperature for 1 h and then 2 L of 40% 2-ME
(vol/vol, in water) were added, followed by incubation
at room temperature for another hour. This solution
was further diluted with 20 L of 2000 mMNaCl, 10 L
of ACN, 134 L of 50 mM NH4HCO3, and then a portion
of 5 L of trypsin solution (1 g/L) was added. The
solution was incubated at 37 °C in the dark. Three hours
later, another 5 L of trypsin solution (1 g/L) was
added, followed by incubation at 37 °C in dark for a
further 16 h. The resulting peptides were desalted using
HLB material (Waters), which was packed in-house in
TopTips (10–200 L; Glygen, Columbia, MD, USA). Solu-
tion of 2% ACN (vol/vol) was used as equilibration and
washing solutions and 70% (vol/vol) ACN solution was
used to elute the peptides.
Esterification of Protein Digests
A dried mixture of the nine-protein digest (equivalent
to a total of 30 g of initial proteins) was incubated with
60 L of anhydrous alcohol (methanol, ethanol, propa-
nol, or butanol) at 37 °C for 1 h. After incubation, 240 L
of alcoholic HCl was added (2500 mM methanolic HCl,
ethanolic HCl, propanolic HCl, or butanolic HCl), and
the solution was incubated at 37 °C for 1 h. Acid alcohol
solutionswere prepared according to a published protocol
[22]. The reaction mixture was dried in SpeedVac and the
above procedure was repeated and dried.
Preparation of Internal Mass Calibrant with
Shifted Mass Defect
Lyophilized YGK peptide (10 nmol) was dissolved in 20
L of 3-IBol. The solution was incubated at 37 °C for
1 h, followed by addition of 80 L of a mixture of 3-IBol
and ClTMS (462:200 vol/vol). The resulting solution
was incubated at 37 °C for another hour, and then dried
using the SpeedVac. After reconstitution with 500 L of
0.5% (vol/vol) FA, 1 L of the solution (equivalent to 20
pmol) was spiked to nine-protein digest solutions,
either esterified or not (as control).
LC-Tandem Parallel Fragmentation Mass
Spectrometry of Nine-Protein Digest
Dried peptide mixtures were dissolved in 100 L of
0.1%TFA solution (equivalent to 0.3 g/L of initial
proteins). Each peptide mixture was spiked with the
modified YGK peptide (1 L of 20 pmol/ L solution).
A solution of 30 L of this spiked sample was analyzed.
LC separation of the peptides were run at a flow rate of
50 L/min with a binary gradient: 1%B at 0 min¡ 1%B
2127J Am Soc Mass Spectrom 2009, 20, 2124–2134 SHIFTING FORBIDDEN ZONE BY ESTERIFICATIONat 5 min¡ 12%B at 7 min¡ 55%B at 100 min¡ 75%B
at 110 min¡ 1%B at 110.1 min ¡ 1%B at 120 min. MS
analysis was run along the course of peptide separation
on a QSTAR Elite mass spectrometer. Key instrument
parameters for the MS experiment were: IS 5500 V, GS1
20, DP 100 V, FP 280 V, DP2 15 V, Q0 60 V, CAD 5, and
m/z range 100–1500.
Preparation of Protein Digests from Cell Lysates
Cultured human cells (a total of 8.3  106 epidermal
growth factor stimulated HN-13 cells from an on-going
collaborative project with Drs. Vyomesh Patel and
Silvio Gutkind at the Oral and Pharyngeal Cancer
Branch of the National Institute of Dental and Cranio-
facial Research, National Institutes of Health) were
obtained as a suspension in PBS buffer. The PBS buffer
was removed by centrifuging the cells at 1000  g for 8
min at 4 °C. Cell pellets were reconstituted with 300 L
of extraction buffer. The extraction buffer was made up
of 60 L phosphatases inhibitor no. 1, 60 L of phos-
phatases inhibitor no. 2, 60 L of protease inhibitor
cocktail, 60 L of 100 mM solution of PMSF in isopro-
panol, 60 L of sodium orthovanadate in 0.18% of
hydrogen peroxide, 120 L of 250 mM EDTA, 600 L of
10 PBS solution, and 300 L of 10% Triton X-100, 60
L of sodium orthovanadate in water. This mixture was
brought to a final volume of 6 mL by deionized water.
Cell lysates were incubated on ice bath for 50 min
followed by mixing at 8 °C for 20 min. Supernatant was
isolated from pellet through centrifugation at 5000  g
and at 8 °C for 10 min. The same procedure was
repeated once, except for that the amount of extraction
buffer was 100 L. The combined supernatant was
centrifuged at 14,000  g for 40 min. The protein
content in the resultant supernatant was quantified
using Qubit Fluorometer (Invitrogen, Carlsbad, CA,
USA); the quantitation protocol was followed as pub-
lished by the vendor. Aliquots containing 100 g of
protein were used for trypsin digestion. The trypsin
digestion and peptide esterification protocols were the
same as those used for the nine-protein mixture, except
for that the esterification was done three times.
LC-Tandem Parallel Fragmentation Mass
Spectrometry of Protein Digests from Cell Lysates
Dried peptide mixtures were dissolved in 10 L of HFIP
and further diluted to a final volume of 100 L with
0.1%TFA (equivalent to 0.5 g/L of initial proteins).
Each peptide mixture was spiked with the modified
YGK peptide (1 L of 20 pmol/L solution). A solution
of 30 L of this spiked sample was analyzed. LC
separation of peptides was run at a flow rate of 50
L/min with a binary gradient: 1% B at 0 min ¡ 1% B
at 13 min¡ 12% B at 40 min¡ 55% B at 160 min¡ 75%
B at 180 min¡ 1% B at 180.1 min ¡ 1% B at 200 min.
Solvent compositions were the same as above. MSanalysis was run along the course of peptide separation
on a QSTAR Elite mass spectrometer. Key instrument
parameters for the MS experiment were: IS 5500 V, GS1
20, DP 100 V, FP 280 V, DP2 15 V, Q0 55 V, CAD 5, and
m/z range 100–1000.
Results and Discussion
Scaling Analysis of Peptide Fragment Ions
Mass spectral data were subjected to a unique scaling
analysis [9] that used averagine [8] as the mass refer-
ence. Averagine is a hypothetical amino acid residue
with a mass of 111.0543052 u that is statistically ob-
tained by sampling all of the amino acids in naturally-
occurring proteins [8]. The scaling conversion of the
peptide ion mass from the IUPAC scale (12C  12 u as
the mass reference) to the averagine scale (averagine
mass  111 u* as the mass reference with zero mass
defect; u*: the mass unit on the averagine scale) uses a
scaling factor of 0.999493894 ( 111/111.0543052) [9].
The mass defect of an ion on the averagine scale
(MDAvg) was defined to be the difference between the
nominal mass of the ion and its exact mass on the
averagine scale, following similar equations used by
others previously [24, 25].
As the most important and convenient feature, mass
defects on the averagine scale of amino acid residues
are additive, i.e., MDAvg for a peptide fragment ion with
a particular sequence can be calculated based on a sum
of MDAvg values for individual amino acid residues.
Rescaling the residue mass to the averagine scale basi-
cally eliminates the systematic drifting in the mass
defect of peptide ions, which increases with the residue
mass on the IUPAC scale [1, 3, 4, 7].
Internal Mass Calibration Using
Iodine-Containing Fragment Ions
Iodine-containing fragment ions of modified peptide
YGK were used for internal mass calibration of com-
bined spectra of fragment ions generated from tryptic
peptides of cell lysates or a nine-protein mixture. Pep-
tide YGK was esterified with 4-iodobenzoyl alcohol
with acid catalysis. A large quantity of native peptide
fragment ions in combined spectra were purposely
generated using a method of tandem parallel fragmenta-
tion mass spectrometry [22, 26–28], which dissociated
intact peptide ions in the source region first, and subse-
quently in the collision cell on a tandem mass spectrom-
eter. A combined mass spectrum for all of the fragment
ions from cell lysate peptides separated by LC showed
many overlapping fragment ions in every mass-to-
charge unit (Figure 1a).
Using averagine-scaling analysis, native and iodinyl
fragment ions can be readily separated by applying
cutoff values calculated from the averagine-scale mass
defect of iodine-containing ions and instrument analyt-
ical figures of merit [9]. Specifically, the combined
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the [M  H] ion (theoretical m/z 900.3156) and the
iodophenyl fragment ion (theoretical m/z 216.9514) of
the modified YGK peptide. Both of these ions were in
unoccupied spectral regions. The smallest theoretical
MDAvg value for y-ions of the modified YGK peptide
was calculated to be 0.100008 u* for the y2 ion. This
value was subtracted by a value (0.007140 u*) calculated
based on an assumed statistical uncertainty of 15 ppm
for the y2 ion (theoretical m/z 475.9000). The obtained
value (0.092868 u*) was set as the lower threshold for
filtering native peptide fragment ions from the peptide
YGK fragment ions that carried an iodophenyl group.
An upper threshold (0.153589 u*) was calculated simi-
larly, based on the singly-charge peptide molecular ion
(theoretical m/z 900.3156; intrinsic MDAvg 0.140089 u*).
Spectral signals corresponding to ions that passed the
mass defect filtering were used to reconstruct a filtered
mass spectrum, which showed only several ions (Figure
1b). Marked peaks were assignable fragment ions that
contained an iodine atom.
The drastic reduction in data complexity from Figure
1a to b is in agreement with our previous study that
averagine scaling analysis is a simple method for suffi-
ciently separating fragment ions in unoccupied spectral
space from native peptide fragment ions [9]. These
special ions, located in empty space of a peptide mass
spectrum, are free from native ion interference. There-
fore, the maximum possible instrumentation specifica-
tions for mass resolution and mass accuracy can be
achieved for these ions. These ions are excellent candi-
dates for internal mass calibration. Precise calibration of
ion masses is important to compare effects of different
esterifications on shifting mass defect borders of native
fragment ions (see Discussion), as well as to averagine-
Figure 1. Zoomed mass spectrum of fragment
dissociation of peptides in a cell lysate digest (1-
1-b shows ions that have passed averagine-scal
identified as fragment ions (y ions and fragme
asterisks) from the modified YGK peptide.scaling analysis. Use of ions in unoccupied spectralspace for internal mass calibration is a previously
explored concept [15].
Theoretical Changes in the Averagine-Scale Mass
Defect Upon Esterification of the Side-Chain
Carboxylate Groups of Asp and Glu
Averagine-scale mass defects for amino acid residues
were plotted against their nominal masses (Figure 2) to
establish a mass defect plot [24, 25] on the averagine
scale [9]. Amino acid residues distributed about evenly
at both sides of the zero MDAvg line (blue dotted line in
Figure 2). The top three amino acid residues with the
largest mass sufficiency on the averagine scale were
generated by tandem parallel collision-induced
set of 1-a is for the spectrum with less zooming;
ss defect filtering parameters. Most of ions are
ns of the labeling group that are marked with
Figure 2. The averagine-scale mass defect plot of amino acid
residues. Cys* residue is modified with iodoacetamide and Cys**
residue is modified with 4-vinylpyridine. Asp and Glu residuesions
a). In
e ma
nt ioand their esterification derivatives are labeled as red dots.
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group of the correlation. The top five amino acid
residues with largest mass defects on the averagine
scale were two modified Cys residues, Asp, Glu, and
Tyr; all of them have atoms (oxygen and/or sulfur)
with significant mass defects.
In this mass defect plot (Figure 2), alkylated cysteine
residues had the largest MDAvg values, due to the
presence of sulfur atom. Their locations on the plot
depended on the alkylation reagents used. The MDAvg
value of an alkylation group decreases with the increase
in its number of hydrogen and/or nitrogen atoms;
accordingly, the MDAvg value of the alkylated cysteine
residue decreases. Thus, alkylation groups with long
aliphatic chains would reduce MDAvg values. There-
fore, the importance of cysteine-rich sequences for
defining the border for unoccupied mass spectral space
is limited due to the possibility of long aliphatic chain
attachment as well as to the low abundance of cysteine
in naturally-occurring proteins. The mass defect label-
ing of Cys on peptides has been shown to be a valuable
approach for improving proteome analysis [10].
Amino acid residues with large MDAvg values that
followed alkylated cysteine residues were Asp (MDAvg
0.031272 u*), Glu (MDAvg 0.022715 u*), and Tyr (MDAvg
0.019198 u*) (Figure 2). While chemical modification of
Tyr is not a common procedure in peptide mass spec-
trometry, esterification of peptidyl carboxylates using
methanolic HCl is routinely used in phosphopeptide
and phosphoproteome analysis [29]. This chemical re-
action is generally considered to be quantitative, and
reagents used can be readily removed. Methylesterifi-
cation of peptidyl carboxylates prevents interference
of these groups during phosphopeptide enrichment
procedures.
The additivity of MDAvg allows the prediction that
esterification of Asp and Glu carboxylate groups will
decrease MDAvg values of these residues. Esterification
of the carboxylate groups with methanol, ethanol, pro-
panol, and butanol will decrease the averagine-scale
mass defect by 0.008556595 u*, 0.017113191 u*,
0.025669786 u*, and 0.034226381 u*, respectively
(Table 1). With significant mass defect decreases of Asp
and Glu, Tyr residue becomes the limiting residue and
plays a controlling role in defining the high-end border
of the MDAvg distribution plot for native peptides
fragment ions (see Discussion). To reduce MDAvg of Asp
to be smaller than that of Tyr (MDAvg  0.012074 u*),
esterification of the Asp carboxylate with ethanol is
Table 1. IUPAC mass defect (MDIUPAC) and averagine-scale mass
Modification EMIUPAC NMIUPAC MDIUPA
–H 1.007825 1 0.0078
–CH3 15.023475 15 0.0234
–CH2CH3 29.039125 29 0.0391
–CH2CH2CH3 43.054775 43 0.0547
–CH2CH2CH2CH3 57.070425 57 0.070425minimally required, which decreases MDAvg of Asp by
0.017113191 u* (Figure 2). When the statistical uncer-
tainty in mass determination of fragment ions is also
considered, a further decrease in MDAvg is essential. For
example, addition of the aliphatic chain using butanol is
calculated to be sufficient for reducing the Glu and Asp
MDAvg values to be smaller than that for the a4-ion of
YYYY (MDAvg 0.057539878 u*) under an assumed sta-
tistical mass accuracy of 15 ppm.
Theoretical MDAvg Distribution Plots of Peptide
Fragment Ions and Effects of Esterification of
Peptidyl Carboxylates
The distribution plot of ion counts versus MDAvg is
termed the MDAvg distribution plot. Distributions of
peptide fragment ions with different MDAvg values
were plotted in Figure 3. These fragment ions were
esterified theoretically with different alcohols, when it
was determined that such esterification was warranted
on the basis of theoretical possibility. Ion frequency
counts were based on a bin size of MDAvg  0.0075 u*,
which was equivalent to 10 ppm in statistical mass error
for an ion with m/z 750. Figure 3a was for distribution
plots for total fragment ions and Figure 3b, c, and d
were for a-, b- and y-type fragment ions, respectively.
The right end of an MDAvg distribution plot defined the
high-end border of the mass defect distribution of
fragment ions. In all figures, this border was found to
decrease with increase in the alkyl chain length of
modifying alcohols, from methanol to n-butanol. Differ-
ent esterifications had much larger effect on y-ions
(Figure 3b) than on a- and b-ions (Figure 3c and d).
The different effects of esterification on the MDAvg
distributions of peptide fragment ions of different types
were attributed to the systematic differences of elemen-
tal compositions of these ion types. The MDAvg values
were listed for a2, b2, and y2 ions with a sequence of
Asp-Asp in Table 2. Ion b2 had the largest MD
Avg of
0.0382 u*, followed by the y-type (MDAvg of 0.0367 u*),
and then the a-type (MDAvg of 0.0190 u*). The limiting
role of b-type fragment ions for defining the border of
unoccupied spectral space was also shown in an MDAvg
distribution plot (Figure 4). The b-ion distribution re-
sided at the highest end (red). Although the y-type ions
(blue) have MDAvg values close to the b-type ions, in
practice, they are less important in defining the MDAvg
distribution border. Commonly in proteome analysis,
t (MDAvg) of the added aliphatic chain on a carboxylate group
EMAvg NMAvg MDAvg MDAvg
1.007315 1 0.007315 0
15.015872 15 0.015872 0.008557
29.024428 29 0.024428 0.017113
43.032985 43 0.032985 0.025670defec
C
25
75
25
7557.041541 57 0.041541 0.034226
d un
2130 BAJRAMI ET AL. J Am Soc Mass Spectrom 2009, 20, 2124–2134peptides are generated by trypsin digestion, which
produces peptides with either Lys or Arg C-terminus.
Lys (MDAvg 0.030133 u*) and Arg (MDAvg 0.022107
u*) residues are mass sufficient on the averagine scale,
as shown in Figure 1. The y-ions terminated with these
two residues, thus, have significantly reduced mass
defects, which shift the MDAvg distribution lower than
that for a-type ions (Figure 4). A recent study has
reported the peptide ion mass distribution dependence
on proteases, which produce characteristic types of
peptides [14].
Figure 3. Theoretical averagine-scale mass def
combinatorial amino acid sequences. In 3-a, fil
ions, followed by methyl esterified (red), ethyl
esterified fragment ions (purple); 3-b, c and d
(purple), OPr (green), OEt (blue), OMe (red), an
Table 2. Mass defects of different types of dipeptidyl fragment
Ion type Elemental composition EMIUPAC N
a2 C9H15N2O5 231.0980
b2 a2 ion  [CO] 259.0929
y2 a2 ion  [CO]  H2O 277.1035
y2  R a2 ion  C7H15N4O3 434.2124
y2  K a2 ion  C7H12N2O3 403.1828 403Experimental Observation of MDAvg Distribution
of Peptide Fragment Ions
Tryptic peptides, with different esterifications, from a
nine-protein mixture and from lysates of cultured hu-
man cells were analyzed by LC-tandem parallel colli-
sion induced dissociation mass spectrometry. Com-
bined spectra for all fragment ions between m/z 100 and
m/z 1000 for all peptides eluted from LC were obtained.
The combined spectra were smoothed and calibrated as
described above. After mass conversion to the averag-
istribution plots for peptide fragment ions with
ray-colored curve shows unmodified fragment
fied (blue), propyl esterified (green), and butyl
nnotated similarly. Color codes from left: OBt
modified (gray, filled).
with a sequence of Asp-Asp
PAC MDIUPAC EMAvg NMAvg MDAvg
0.0980 230.9810 231 0.0190
0.0929 258.9618 259 0.0382
0.1035 276.9633 277 0.0367
0.2124 433.9926 434 0.0074ect d
led g
esteri
are aions
MIU
231
259
277
4340.1828 402.9787 403 0.0212
2131J Am Soc Mass Spectrom 2009, 20, 2124–2134 SHIFTING FORBIDDEN ZONE BY ESTERIFICATIONine scale and calculation of MDAvg, ions were sorted
according to their intensities. The top 8000 ions (out of
ca.12,000 of total ions) for peptides of the nine-protein
mixture (Figure 5a) were used to construct an MDAvg
distribution plot. Tryptic peptides for cell lysates were
analyzed similarly, and the top 11,000 ions (out of ca.
16,000 of total ions) were used to make the correspond-
ing MDAvg distribution plot (Figure 5b).
Both plots showed retreat of the high mass defect
border with increase in the aliphatic chain length of
Figure 4. Comparison of averagine-scale mass defect distribu-
tion plots of different types of fragment ions. Ion types are
annotated on the figure. Color codes from left: [y ionsLysine]
(purple), [y ionsArginine] (green), a ions (black), y ions (blue),
and b ions (red).
Figure 5. Averagine-scale mass defect distribut
cell lysates (a), and a nine-protein mixture (b). T
were generated using a method of tandem par
gray-colored curve shows unmodified fragme
esterified (blue), and butyl esterified fragment
unmodified fragment ions, followed by methyl e
(green), and butyl esterified fragment ions (purp
defects for pY immonium ion and CyPAA ion
(green), OEt (blue), OMe (red), and unmodified
(purple), OPr (green), OEt (blue), and OMe (red), anesterifying alcohols (Figure 5). The observed distribu-
tions were similar to theoretical ones (Figure 3a). The
increase in the chain length results in diminishment of
ions at this border, and thus a shift of unoccupied mass
spectral space. Considering the fact that experimental
data included fragment ions generated through multi-
ple gas-phase fragmentations, the similarity between
theoretical and experimental MDAvg distribution plots
suggests that observed fragment ions from multiple
dissociations have similar elemental compositions to
those of a- and b-ions. The narrower distribution for the
nine-protein digest is consistent with the fact that this
digest mixture contains less diverse amino acid se-
quences than those of cell lysate digests.
Effects of Esterification on the Specificity of
Phosphoryl Fragment Ions
Esterification is a common sample preparation proce-
dure for mass spectrometry of a phosphopeptide, which
is a target application of this study. Phosphopeptides
can produce native and modified fragment ions that
contain phosphorus atoms, and phosphoryl fragment
ions thus have increased mass defect, compared with
nonphosphoryl isobaric ions. For phosphate-specific mass
spectrometry [30], two positive phosphoryl ions are of
particular interest: the pY immonium ion [19, 20] (elemen-
tal composition, C8H11NO4P; EMIUPAC, 216.04,257 u;
MDAvg, 0.06,677 u*) and CyPAA ion [22] (elemental com-
position, C7H9NO3P; EMIUPAC, 186.03,146 u; MDAvg,
0.06,269 u*). The pY immonium ion can be generated from
pY peptides upon collisional activation. The CyPAA ion,
aspired by characteristics of the pY immonium ion, can
lots of fragment ions of peptides from digests of
peptide fragment ions in the combined spectra
fragmentation mass spectrometry. In 5-a, filled
ns, followed by methyl esterified (red), ethyl
green). In 5-b, filled gray-colored curve shows
ied (red), ethyl esterified (blue), propyl esterified
cations that correspond to averagine scale mass
hown. Color codes for Figure 5a from left: OBt
, filled). Color codes for Figure 5b from left: OBtion p
hese
allel
nt io
ions (
sterif
le). Lo
are s
(grayd unmodified (gray, filled).
2132 BAJRAMI ET AL. J Am Soc Mass Spectrom 2009, 20, 2124–2134be generated from pS peptides whose phosphate groups
are modified by 2-aminophenylamine in solution [22].
The specificities of these ions as markers for detecting
the presence of pY or pS peptides are predictable
according to relative locations of these phosphoryl ions
on MDAvg distribution plots (Figure 5). The two phos-
phoryl fragment ions have similar MDAvg values and
are located at the high mass defect border on the MDAvg
distribution plot that borders unoccupied spectral
space. It is predictable that these ions may be separated
with little interference from the main population of
nonphosphoryl ions (Figure 5). Among the interfering
ions are Asp- and Glu-containing ones [18–22]. This is
because the acidic amino acid residues contain oxygen
atoms that have significant mass defect. The MDAvg
sum of two Asp residues (MDAvg 0.062544 u*) or three
Glu residues (MDAvg 0.068145 u*) is roughly equal to
the MDAvg values of pY immonium ion (MDAvg 0.06,677
u*) for pY peptides or the CyPAA ion (MDAvg 0.06,269
u*) for modified pS peptides. Therefore, Asp- and Glu-rich
fragment ions interfere with the phosphoryl ions, compro-
mising the use of these phosphoryl ions in phosphate-
specific mass spectrometry. To fully separate the phos-
phoryl ions from native peptide fragment ions, which
should increase both the selectivity and sensitivity for
detecting the phosphoryl ions, a shift of the forbidden
Figure 6. Effects of esterifications on experimen
and cyclophosphoramidate ion. Total ion chrom
were produced during LC-tandem parallel fragm
lysate proteins without esterification (a), and wit
chromatograms for the ion masses that are equ
0.020 (b) and (e) and a cyclophosphoramidate io
Numbers of observed peaks for both the two ion
esterification (to ethanol esterification and to butanolzone is helpful. The border defined by ions with large
mass defects needs to be pushed back. This can be done
by introducing peptide modifying groups with a high
hydrogen and/or nitrogen content (Figure 5); both
atoms have mass sufficiency on the IUPAC and aver-
agine scale.
The phosphoryl ion specificity and effects of esteri-
fication on potential elimination of background frag-
ment ions, which have similar mass-to-charge ratios to
pY immonium and CyPAA ions, were examined exper-
imentally. Extracted ion chromatograms for the ion
masses that are equal to those of the pY immonium ion
(m/z 216.043–216.063; Figure 6b and e; Supplementary
data, Figure S1, which can be found in the electronic
version of this article) and CyPAA ion (m/z 186.031–
186.051; Figure 6c and f; Figure S1) were reconstructed
for peptide fragment ions that were produced during
LC-tandem parallel fragmentation mass spectrometry
of tryptic digests of cell lysate proteins without esteri-
fication (Figure 6a), with methanol esterification (Figure
6d), with ethanol esterification (Figure S1) and with
butanol esterification (Figure S1). The number of ob-
served peaks for both ion masses (Figure 6 and Figure
S1) was fewer than the theoretical prediction based on
ion mass defect distribution plots (Figure 5). This was
not surprising because for a particular mass-to-charge
n specificity of phosphotyrosine immonium ion
rams obtained from peptide fragment ions that
tion mass spectrometry of tryptic digests of cell
hanol esterification (d) are shown. Extracted ion
those of the pY immonium ion (m/z 216.043 
186.031  0.020 (c) and (f) were reconstructed.
ses decreased from no esterification to methanoltal io
atog
enta
h met
al to
n m/z
masesterification, Figure S1).
2133J Am Soc Mass Spectrom 2009, 20, 2124–2134 SHIFTING FORBIDDEN ZONE BY ESTERIFICATIONratio not all of the interfering ions on the MDAvg
distribution plot could be observed. However, a global
mass defect distribution arguably mimics potential iso-
baric ions that can be generated through unspecified
multiple fragmentation pathways but with similar ele-
mental compositions to amino acid residues. A compar-
ison among different esterification samples revealed
that numbers of observable peaks for selected ion mass
ranges decreased from no esterification to methanol
esterification to ethanol esterification and to butanol
esterification (Figure 6 and Figure S1), especially for the
CyPAA ion. This was in agreement with theoretical
predictions, which showed retreat of high mass defect
border upon esterification (Figure 5). In addition, it was
observed that an increase in the aliphatic chain length
increased mass spectral signal intensity, although this
enhancement was peptide sequence dependent (data
not shown). This was likely due to the increased hydro-
phobicity of modified peptides [31–34]. Enhanced sig-
nals should also be beneficial to mass spectrometry of
phosphopeptides, which are often substoichiometric
and of low abundance.
Conclusions
Underappreciated beneficial effects of peptide esterifi-
cation for mass spectrometry of complex proteome
digests should be further investigated. With enhanced/
new functions of contemporary mass spectrometers,
methods for analysis of phosphopeptides based on
marker phosphoryl ions [18, 20, 22] are being revisited
[23]. Esterification of peptidyl carboxylates, a common
procedure in phosphopeptide preparation for mass
spectrometry, shifts Asp- and Glu-rich fragment ions
from being limiting ions for the high mass defect border
of the mass defect distribution plot for peptide frag-
ment ions. Diminished interference of phosphoryl
marker ions will improve the specificity of the marker
ions based on mass-to-charge determination alone for
validating phosphopeptides in complex mixtures [22].
Esterification of peptidyl carboxylates should improve
probability-based mass spectrometric analysis of intact
phosphopeptides as well [35]. In general, ultra-high
resolving and accurate mass spectrometers should
surely be beneficial to these analyses. Retreating of
the high mass defect border of the mass defect
distribution plot of peptide fragment ions can also be
advantageously used to improve the specificity of
nearby fragment ions in unoccupied mass spectral
space. These special fragment ions can be generated
by chemical modification and gas-phase reaction;
they have great potential in various types of pro-
teome analysis [9, 36].
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